These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2880779)

  • 1. [Psychophysiologic aspect of regulating dyadic interpersonal interaction].
    Medvedev VI; Zav'ialova EK; Ovchinnikov BV; Posokhova ST
    Fiziol Cheloveka; 1986; 12(5):754-60. PubMed ID: 2880779
    [No Abstract]   [Full Text] [Related]  

  • 2. GYKI-12 743, a novel antihypertensive compound with special alpha-adrenergic blocking profile.
    Jaszlits L; Rabloczky G; Csókás G; Bódi I; Kürthy M; Horváth E; Kovács A; Jednákovits A; Arányi P; Mátyus P
    Acta Physiol Hung; 1990; 75 Suppl():155-6. PubMed ID: 1973559
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats.
    Horváth E; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():145-6. PubMed ID: 1973558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alpha-adrenoblocking activity of a newly synthesized derivative of 1,4-benzodioxane].
    Staneva D; Spasov V; Ivanov D
    Eksp Med Morfol; 1984; 23(2):87-91. PubMed ID: 6147242
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular and cardiac electrophysiological activity of GYKI-12 743 in isolated tissue preparations.
    Jednákovits A; Kovács A; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():157-8. PubMed ID: 1973560
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lactogenic effect of pyrroxan, a Soviet alpha-adrenoblockader].
    Kolodina LN; Poskalenko AN; Korkhov VV; Barannikova TA
    Akush Ginekol (Mosk); 1976 Aug; (8):60-2. PubMed ID: 11702
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of single administration of adrenergic alpha receptor blockader piroxan on bronchial patency in patients with bronchial asthma].
    Zonis IaM; Zonis BIa
    Ter Arkh; 1981; 53(11):108-10. PubMed ID: 6122273
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idazoxan and blood gas changes.
    Raptopoulos D; Koutinas A; Moustardas N; Papasteriadis A
    Vet Rec; 1988 Jan; 122(2):47. PubMed ID: 2896410
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteers.
    Grasby PM; Begg EJ; Gartside SE; Cowen PJ
    Biol Psychiatry; 1989 Aug; 26(4):412-6. PubMed ID: 2569897
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idazoxan: a novel xylazine antagonist.
    Doherty T
    Vet Rec; 1985 Aug; 117(6):135. PubMed ID: 2864759
    [No Abstract]   [Full Text] [Related]  

  • 13. [3H]WB4101 labels S1 serotonin receptors in rat cerebral cortex.
    Norman AB; Battaglia G; Morrow AL; Creese I
    Eur J Pharmacol; 1984 Nov; 106(2):461-2. PubMed ID: 6152223
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of rausedyl and pyrroxan on autoregulation of cerebral circulation].
    Gaevyĭ MD; Pogorelyĭ VE
    Biull Eksp Biol Med; 1983 Jul; 96(7):56-9. PubMed ID: 6135465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotropic responses to WB4101 in anaesthetised and conscious rats.
    Mottram DR; Kapur H
    Gen Pharmacol; 1981; 12(6):471-5. PubMed ID: 6118316
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of some WB4101 analogues bearing a naphthodioxanic nucleus.
    Castagnino E; Strappaghetti G; Corsano S; Gallucci P; Brasili L; Giardinà D
    Farmaco Sci; 1984 Jul; 39(7):569-74. PubMed ID: 6148262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-adrenoreceptor reagents. 4. Resolution of some potent selective prejunctional alpha 2-adrenoreceptor antagonists.
    Welbourn AP; Chapleo CB; Lane AC; Myers PL; Roach AG; Smith CF; Stillings MR; Tulloch IF
    J Med Chem; 1986 Oct; 29(10):2000-3. PubMed ID: 2876101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of drugs possessing antialcoholic activity on ethanol pharmacokinetics].
    Lelevich VV; Pron'ko PS; Liopo AV; Deniskovets AA
    Farmakol Toksikol; 1989; 52(4):85-8. PubMed ID: 2572455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.
    Yamada S; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1980 Oct; 215(1):176-85. PubMed ID: 6109014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.
    Elliott HL; Jones CR; Reid JL
    J Hypertens Suppl; 1983 Dec; 1(2):109-11. PubMed ID: 6152738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.